Notably, a DNA polymorphism within a DNase hypersensitive site 5′ of TREM2, rs9357347‐C, also associates with reduced AD risk and increased TREML1 and TREM2 levels (Carrasquillo et al, 2017). Here, TREML1 is linked to Alzheimer disease.